Details for Patent: 7,429,602
✉ Email this page to a colleague
Summary for Patent: 7,429,602
Title: | Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva |
Abstract: | Treating allergic conjunctivitis by administered aqueous solutions containing epinastine, optionally in the form of its racemate or its enantiomers and optionally, in the form of the pharmacologically acceptable acid addition salts thereof, to the conjunctiva. |
Inventor(s): | Trach; Volker (Biberach, DE), Duschler; Gerold (Ehingen, DE) |
Assignee: | Boehringer Ingelheim Pharma GmbH & Co. Kg (Ingelheim, DE) |
Application Number: | 11/863,008 |
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 7,429,602
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,429,602
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 199 54 516 | Nov 12, 1999 |
International Family Members for US Patent 7,429,602
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 026424 | ⤷ Try a Trial | |||
Austria | 353218 | ⤷ Try a Trial | |||
Australia | 1138101 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |